Clene Newsroom

Maxim Group Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $20

Futu NewsDec 12 04:31

H.C. Wainwright Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $31

Futu NewsDec 10 22:32

Clene Price Target Maintained With a $23.00/Share by D. Boral Capital

Dow JonesDec 10 22:27

Clene Is Maintained at Buy by D. Boral Capital

Dow JonesDec 10 22:27

Clene Analyst Ratings

BenzingaDec 10 22:17

Benchmark Maintains Buy on Clene, Lowers Price Target to $84

BenzingaNov 22 22:57

Clene Price Target Cut to $83.00/Share From $86.00 by Canaccord Genuity

Dow JonesNov 15 00:09

Clene Price Target Maintained With a $23.00/Share by D. Boral Capital

Dow JonesNov 14 06:37

Clene Is Maintained at Buy by D. Boral Capital

Dow JonesNov 14 06:37

Clene Analyst Ratings

BenzingaNov 14 06:27

H.C. Wainwright Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $31

Futu NewsNov 13 23:33

Clene's Strategic and Financial Strengths Justify Buy Rating Amid Promising ALS Therapeutic Developments

TipRanksNov 13 22:47

Clene Price Target Maintained With a $23.00/Share by EF Hutton

Dow JonesOct 24 20:15

Clene Analyst Ratings

BenzingaOct 24 17:42

H.C. Wainwright Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $31

Futu NewsOct 23 22:32

Strategic Advancements and Robust Trial Design Drive Buy Rating for Clene

TipRanksOct 23 22:18

Benchmark Co. Sticks to Their Buy Rating for Clene (CLNN)

TipRanksOct 11 19:08

Clene Is Maintained at Buy by Canaccord Genuity

Dow JonesOct 4 22:55

Clene Analyst Ratings

BenzingaOct 2 22:55

Analysts Are Bullish on These Healthcare Stocks: Clene (CLNN), I-MAB (IMAB)

TipRanksSep 18 20:22